Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Buy
65
STNE Quote, Financials, Valuation and Earnings
Last price:
$15.78
Seasonality move
:
4.59%
Day range:
$14.29 - $14.98
52-week range:
$7.72 - $15.27
Dividend yield:
0%
P/E ratio:
7.97x
P/S ratio:
1.84x
P/B ratio:
1.99x
Volume:
4.8M
Avg. volume:
6.5M
1-year change:
27.65%
Market cap:
$3.9B
Revenue:
$2.4B
EPS (TTM):
-$0.78
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $622.9M | $849.8M | $1.7B | $2.3B | $2.4B | |
| Revenue Growth (YoY) | 2.77% | 36.44% | 105.76% | 30.2% | 4.29% | |
| Cost of Revenues | $150.9M | $318.3M | $517.8M | $597.6M | $631.7M | |
| Gross Profit | $472M | $531.6M | $1.2B | $1.7B | $1.7B | |
| Gross Profit Margin | 75.78% | 62.55% | 70.39% | 73.75% | 73.4% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $176M | $339.1M | $510.6M | $578.4M | $603.2M | |
| Other Inc / (Exp) | -$36M | -$270.4M | -$224M | -$40.3M | -$733.7M | |
| Operating Expenses | $176M | $339.1M | $510.6M | $578.4M | $603.2M | |
| Operating Income | $296M | $192.5M | $720.3M | $1.1B | $1.1B | |
| Net Interest Expenses | $39M | $190.6M | $571.4M | $665.6M | $595.5M | |
| EBT. Incl. Unusual Items | $220.9M | -$268.4M | -$75.1M | $394.8M | -$189.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $56.9M | -$12.7M | $27M | $74.2M | $91.2M | |
| Net Income to Company | $164.1M | -$255.8M | -$102.1M | $320.6M | -$280.9M | |
| Minority Interest in Earnings | $3.3M | $3.4M | $1.4M | -$1.7M | -$1.5M | |
| Net Income to Common Excl Extra Items | $167.3M | -$252.3M | -$100.7M | $319M | -$282.4M | |
| Basic EPS (Cont. Ops) | $0.58 | -$0.82 | -$0.32 | $1.02 | -$0.94 | |
| Diluted EPS (Cont. Ops) | $0.57 | -$0.82 | -$0.32 | $0.95 | -$0.94 | |
| Weighted Average Basic Share | $289.3M | $308.9M | $311.9M | $312.6M | $301.7M | |
| Weighted Average Diluted Share | $293.7M | $308.9M | $311.9M | $319.3M | $301.7M | |
| EBITDA | $337.7M | -$81.3M | $261.2M | $710.1M | $184.2M | |
| EBIT | $287.5M | -$175.5M | $106M | $534.2M | $7.2M | |
| Revenue (Reported) | $622.9M | $849.8M | $1.7B | $2.3B | $2.4B | |
| Operating Income (Reported) | $296M | $192.5M | $720.3M | $1.1B | $1.1B | |
| Operating Income (Adjusted) | $287.5M | -$175.5M | $106M | $534.2M | $7.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $151.4M | $370.2M | $491.1M | $595.3M | $593.7M | |
| Revenue Growth (YoY) | -1.5% | 144.49% | 32.65% | 21.23% | -0.27% | |
| Cost of Revenues | $43.9M | $128.9M | $138.7M | $163.6M | $159.3M | |
| Gross Profit | $107.5M | $241.3M | $352.3M | $431.7M | $434.4M | |
| Gross Profit Margin | 71.02% | 65.18% | 71.75% | 72.52% | 73.17% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $51.3M | $118.9M | $132.3M | $158.9M | $148.6M | |
| Other Inc / (Exp) | -$8.3M | -$67.9M | -$11.9M | -$21.2M | -$22.9M | |
| Operating Expenses | $51.3M | $118.9M | $132.3M | $158.9M | $148.6M | |
| Operating Income | $56.2M | $122.4M | $220M | $272.9M | $285.8M | |
| Net Interest Expenses | $9.5M | $109.9M | $149.1M | $154M | $154.2M | |
| EBT. Incl. Unusual Items | $38.5M | -$55.4M | $59M | $97.8M | $108.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.5M | $4.4M | $15.6M | $22.3M | $20.6M | |
| Net Income to Company | $29M | -$59.8M | $43.4M | $75.5M | $88.1M | |
| Minority Interest in Earnings | $3.9K | -$35.6K | $182.5K | -$124K | -$390.5K | |
| Net Income to Common Excl Extra Items | $29M | -$59.9M | $43.6M | $75.3M | $87.8M | |
| Basic EPS (Cont. Ops) | $0.09 | -$0.19 | $0.14 | $0.24 | $0.31 | |
| Diluted EPS (Cont. Ops) | $0.09 | -$0.19 | $0.13 | $0.24 | $0.31 | |
| Weighted Average Basic Share | $309.6M | $310.3M | $312.7M | $309.1M | $279.8M | |
| Weighted Average Diluted Share | $314.8M | $310.3M | $324.9M | $316.1M | $286.1M | |
| EBITDA | $70.8M | $22.7M | $135.7M | $182.4M | $219.1M | |
| EBIT | $55.4M | -$12.7M | $94.9M | $138.5M | $175.1M | |
| Revenue (Reported) | $151.4M | $370.2M | $491.1M | $595.3M | $593.7M | |
| Operating Income (Reported) | $56.2M | $122.4M | $220M | $272.9M | $285.8M | |
| Operating Income (Adjusted) | $55.4M | -$12.7M | $94.9M | $138.5M | $175.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $616.3M | $1.1B | $1.9B | $2.4B | $2.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $159.2M | $402.3M | $527M | $622.3M | $626M | |
| Gross Profit | $457M | $662.1M | $1.3B | $1.8B | $1.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $183.9M | $407.3M | $523.2M | $604.9M | $591.4M | |
| Other Inc / (Exp) | -$41.6M | -$329.7M | -$171.6M | -$49.5M | -$681M | |
| Operating Expenses | $183.9M | $407.3M | $523.2M | $604.9M | $591.4M | |
| Operating Income | $273.2M | $254.8M | $817.4M | $1.2B | $1.1B | |
| Net Interest Expenses | $25.8M | $288.6M | $611.7M | $670.6M | $593.1M | |
| EBT. Incl. Unusual Items | $205.8M | -$363.5M | $34.1M | $435.1M | -$128.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $50.6M | -$18.5M | $37.7M | $81M | $89.8M | |
| Net Income to Company | $157.2M | -$344.6M | $1.2M | $352.7M | -$268.2M | |
| Minority Interest in Earnings | $2M | $564K | $1.6M | -$2M | -$1.8M | |
| Net Income to Common Excl Extra Items | $157.2M | -$341.1M | -$2.1M | $352.1M | -$220.3M | |
| Basic EPS (Cont. Ops) | $0.53 | -$1.10 | -$0.01 | $1.13 | -$0.76 | |
| Diluted EPS (Cont. Ops) | $0.53 | -$1.11 | -$0.02 | $1.05 | -$0.78 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $310.3M | -$127.5M | $369.2M | $758M | $268.2M | |
| EBIT | $258.3M | -$242.1M | $208.5M | $579.1M | $91.8M | |
| Revenue (Reported) | $616.3M | $1.1B | $1.9B | $2.4B | $2.4B | |
| Operating Income (Reported) | $273.2M | $254.8M | $817.4M | $1.2B | $1.1B | |
| Operating Income (Adjusted) | $258.3M | -$242.1M | $208.5M | $579.1M | $91.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $151.4M | $370.2M | $491.1M | $595.3M | $593.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $43.9M | $128.9M | $138.7M | $163.6M | $159.3M | |
| Gross Profit | $107.5M | $241.3M | $352.3M | $431.7M | $434.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $51.3M | $118.9M | $132.3M | $158.9M | $148.6M | |
| Other Inc / (Exp) | -$8.3M | -$67.9M | -$11.9M | -$21.2M | -$22.9M | |
| Operating Expenses | $51.3M | $118.9M | $132.3M | $158.9M | $148.6M | |
| Operating Income | $56.2M | $122.4M | $220M | $272.9M | $285.8M | |
| Net Interest Expenses | $9.5M | $109.9M | $149.1M | $154M | $154.2M | |
| EBT. Incl. Unusual Items | $38.5M | -$55.4M | $59M | $97.8M | $108.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.5M | $4.4M | $15.6M | $22.3M | $20.6M | |
| Net Income to Company | $29M | -$59.8M | $43.4M | $75.5M | $88.1M | |
| Minority Interest in Earnings | $3.9K | -$35.6K | $182.5K | -$124K | -$390.5K | |
| Net Income to Common Excl Extra Items | $29M | -$59.9M | $43.6M | $75.3M | $87.8M | |
| Basic EPS (Cont. Ops) | $0.09 | -$0.19 | $0.14 | $0.24 | $0.31 | |
| Diluted EPS (Cont. Ops) | $0.09 | -$0.19 | $0.13 | $0.24 | $0.31 | |
| Weighted Average Basic Share | $309.6M | $310.3M | $312.7M | $309.1M | $279.8M | |
| Weighted Average Diluted Share | $314.8M | $310.3M | $324.9M | $316.1M | $286.1M | |
| EBITDA | $70.8M | $22.7M | $135.7M | $182.4M | $219.1M | |
| EBIT | $55.4M | -$12.7M | $94.9M | $138.5M | $175.1M | |
| Revenue (Reported) | $151.4M | $370.2M | $491.1M | $595.3M | $593.7M | |
| Operating Income (Reported) | $56.2M | $122.4M | $220M | $272.9M | $285.8M | |
| Operating Income (Adjusted) | $55.4M | -$12.7M | $94.9M | $138.5M | $175.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $470.7M | $806.7M | $286.1M | $448.5M | $845.8M | |
| Short Term Investments | $1.7B | $778.6M | $1.4B | $2B | $1.5B | |
| Accounts Receivable, Net | $3.1B | $3.5B | $4B | $5B | $4.8B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $13M | $30.4M | -- | -- | -- | |
| Other Current Assets | $18.2M | $59.7M | $69.1M | $78.5M | $59.9M | |
| Total Current Assets | $5.6B | $5.4B | $5.8B | $7.7B | $7.4B | |
| Property Plant And Equipment | $138M | $281.6M | $310.4M | $342.4M | $296.7M | |
| Long-Term Investments | $10M | $234.1M | $61.4M | $26.5M | $17.5M | |
| Goodwill | $125.8M | $1B | $1.1B | $1.2B | $336.2M | |
| Other Intangibles | $74.2M | $482M | $564.5M | $651.1M | $546.8M | |
| Other Long-Term Assets | $16.5M | $25.4M | $39.1M | $28.3M | $25.8M | |
| Total Assets | $6.1B | $7.6B | $8B | $10B | $8.9B | |
| Accounts Payable | $34.7M | $66.8M | $112.7M | $105.9M | $108.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $595.5M | $683.1M | $523.3M | $381.1M | $796M | |
| Current Portion Of Capital Lease Obligations | $9.4M | $11.9M | $10.5M | $6.2M | $8.1M | |
| Other Current Liabilities | $5.1M | $30.3M | $67.2M | $25.6M | $47.2M | |
| Total Current Liabilities | $2.6B | $4.1B | $4.8B | $5.9B | $5.4B | |
| Long-Term Debt | $541M | $768.3M | $488.7M | $720.3M | $1.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.2B | $5.1B | $5.5B | $7B | $7B | |
| Common Stock | $14.4K | $13.6K | $14.4K | $15.7K | $12.3K | |
| Other Common Equity Adj | $2.6B | $2.6B | $2.5B | $2.8B | $2.3B | |
| Common Equity | $2.9B | $2.4B | $2.4B | $3B | $1.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $26.7M | $16.3M | $10.6M | $11.1M | $8.3M | |
| Total Equity | $2.9B | $2.4B | $2.4B | $3B | $1.9B | |
| Total Liabilities and Equity | $6.1B | $7.6B | $8B | $10B | $8.9B | |
| Cash and Short Terms | $2.2B | $1.6B | $1.7B | $2.5B | $2.4B | |
| Total Debt | $1.1B | $1.5B | $1B | $1.1B | $2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $322.7M | $873.6M | $364.1M | $994.3M | $980.8M | |
| Short Term Investments | $1.6B | $1.1B | $1.4B | $1.4B | $396.7M | |
| Accounts Receivable, Net | $3B | $4B | $3.8B | $5.4B | $6.1B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $19.7M | $30.8M | $26.1M | -- | -- | |
| Other Current Assets | $47.5M | $50.9M | $44.2M | $76.6M | $83.4M | |
| Total Current Assets | $5B | $6.1B | $5.7B | $8B | $7.8B | |
| Property Plant And Equipment | $154.5M | $344M | $351.4M | $338.5M | $326.4M | |
| Long-Term Investments | $14.4M | $205.6M | $28M | $26.4M | $19.1M | |
| Goodwill | $113.3M | $1.2B | $1.1B | $1.1B | $360.7M | |
| Other Intangibles | $70.2M | $559.9M | $585.4M | $638M | $590.8M | |
| Other Long-Term Assets | $16.5M | $29.5M | $17M | $34.2M | $26.5M | |
| Total Assets | $5.5B | $8.6B | $8B | $10.3B | $9.4B | |
| Accounts Payable | $41.9M | $74.1M | $97.5M | $101.7M | $125.3M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $587.3M | $930.1M | $378.8M | $444.7M | $857.3M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $5.3M | $120.2M | $79.8M | $107.2M | $67.6M | |
| Total Current Liabilities | $2.2B | $4.9B | $4.5B | $5.8B | $5.6B | |
| Long-Term Debt | $501.1M | $658.7M | $522M | $1.2B | $1.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.8B | $5.8B | $5.3B | $7.3B | $7.4B | |
| Common Stock | $13.2K | $15.9K | $14.9K | $15.2K | $13.2K | |
| Other Common Equity Adj | $2.4B | $2.9B | $2.7B | $2.7B | $2.4B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $10.7M | $23.9M | $10.9M | $10.5M | $8.8M | |
| Total Equity | $2.7B | $2.8B | $2.6B | $3B | $2B | |
| Total Liabilities and Equity | $5.5B | $8.6B | $8B | $10.3B | $9.4B | |
| Cash and Short Terms | $1.9B | $1.9B | $1.8B | $2.4B | $1.4B | |
| Total Debt | $1.1B | $1.6B | $900.7M | $1.7B | $2.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $164.1M | -$255.8M | -$102.1M | $320.6M | -$280.9M | |
| Depreciation & Amoritzation | $50.2M | $94.2M | $155.2M | $175.9M | $177M | |
| Stock-Based Compensation | $6.2M | $21M | $41.3M | $50.3M | $43.4M | |
| Change in Accounts Receivable | -$676.8M | -$554.6M | $334.1M | $16.8M | -$524.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11.1M | $669.8M | $326.5M | $330.1M | -$675M | |
| Capital Expenditures | $89.2M | $241.2M | $140.3M | $242.5M | $237M | |
| Cash Acquisitions | -$57.2M | -$887.4M | -$23.5M | -$7.6M | -$36.3M | |
| Cash From Investing | -$1.1B | -$552.9M | -$362.9M | -$169.4M | $295.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.3B | $2.3B | $678.8M | $829.1M | $1.1B | |
| Long-Term Debt Repaid | -$1.5B | -$1.9B | -$1.2B | -$1.1B | -$581.3M | |
| Repurchase of Common Stock | -$15M | -$183.6M | -- | -$58.7M | -$295.9M | |
| Other Financing Activities | $44.9M | $42.2M | -$79.2M | $305.7M | $698.8M | |
| Cash From Financing | $1.4B | $263.6M | -$545M | -$29.8M | $939.5M | |
| Beginning Cash (CF) | $189.7M | $454.4M | $871.9M | $303M | $405.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $286.8M | $380.5M | -$581.4M | $130.9M | $560.4M | |
| Ending Cash (CF) | $479.4M | $834.8M | $293.4M | $436M | $974.4M | |
| Levered Free Cash Flow | -$78.1M | $428.6M | $186.3M | $87.6M | -$912M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $29M | -$59.8M | $43.4M | $75.5M | $88.1M | |
| Depreciation & Amoritzation | $15.5M | $35.3M | $40.9M | $43.9M | $44.1M | |
| Stock-Based Compensation | $4.1M | $5.2M | $13.5M | $5.2M | $14.9M | |
| Change in Accounts Receivable | $117.2M | $299.3M | $490.2M | -$483.3M | $221.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$16.3M | $152M | $224.7M | -$499.5M | $106.5M | |
| Capital Expenditures | $68.9M | $46.2M | $80.1M | $61.9M | $49M | |
| Cash Acquisitions | -$6.5M | -$9.4M | -$738.4K | -$4.5M | -$1.2M | |
| Cash From Investing | -$114.6M | -$143.6M | $9.9M | $545.4M | $13.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $248.4M | $286.7M | $201.9M | $675.3M | $258.4M | |
| Long-Term Debt Repaid | -$220.1M | -$364.8M | -$372.1M | -$162.3M | -$204.6M | |
| Repurchase of Common Stock | -$42.5M | -- | -- | -- | -$143.9M | |
| Other Financing Activities | $42.3M | -$212.6K | -$441.6K | $9M | $44.2M | |
| Cash From Financing | $28.2M | -$68.1M | -$170.6M | $522M | -$45.8M | |
| Beginning Cash (CF) | $448M | $859.3M | $290.9M | $439.6M | $891.7M | |
| Foreign Exchange Rate Adjustment | -$4.1M | -$2.7M | $2M | -$17.4K | -$2.1M | |
| Additions / Reductions | -$102.7M | -$59.6M | $64M | $567.9M | $74.2M | |
| Ending Cash (CF) | $341.2M | $797M | $356.9M | $1B | $963.8M | |
| Levered Free Cash Flow | -$85.3M | $105.8M | $144.6M | -$561.4M | $57.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $157.2M | -$344.6M | $1.2M | $352.7M | -$268.2M | |
| Depreciation & Amoritzation | $52.1M | $114.1M | $160.7M | $179M | $177.1M | |
| Stock-Based Compensation | $8.6M | $22.2M | $49.6M | $42.1M | $53M | |
| Change in Accounts Receivable | -$827.7M | -$372.4M | $524.9M | -$956.8M | $180.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$87.2M | $838.1M | $399.3M | -$394.1M | -$69M | |
| Capital Expenditures | $132.7M | $218.4M | $174.1M | $224.3M | $224.2M | |
| Cash Acquisitions | -$64.9M | -$890.3M | -$14.9M | -$11.3M | -$33.1M | |
| Cash From Investing | -$1.4B | -$581.8M | -$209.4M | $366.1M | -$236M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $910.4M | $2.3B | $594M | $1.3B | $701M | |
| Long-Term Debt Repaid | -$922.5M | -$2B | -$1.2B | -$896.1M | -$623.6M | |
| Repurchase of Common Stock | -$46.7M | -- | -- | -$58.7M | -$439.7M | |
| Other Financing Activities | $35.1M | -$347.3K | -$79.4M | $315.1M | $734M | |
| Cash From Financing | $1.5B | $167.3M | -$647.6M | $662.8M | $371.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $59.1M | $423.6M | -$457.7M | $634.9M | $66.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$220M | $619.7M | $225.1M | -$618.4M | -$293.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $29M | -$59.8M | $43.4M | $75.5M | $88.1M | |
| Depreciation & Amoritzation | $15.5M | $35.3M | $40.9M | $43.9M | $44.1M | |
| Stock-Based Compensation | $4.1M | $5.2M | $13.5M | $5.2M | $14.9M | |
| Change in Accounts Receivable | $117.2M | $299.3M | $490.2M | -$483.3M | $221.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$16.3M | $152M | $224.7M | -$499.5M | $106.5M | |
| Capital Expenditures | $68.9M | $46.2M | $80.1M | $61.9M | $49M | |
| Cash Acquisitions | -$6.5M | -$9.4M | -$738.4K | -$4.5M | -$1.2M | |
| Cash From Investing | -$114.6M | -$143.6M | $9.9M | $545.4M | $13.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $248.4M | $286.7M | $201.9M | $675.3M | $258.4M | |
| Long-Term Debt Repaid | -$220.1M | -$364.8M | -$372.1M | -$162.3M | -$204.6M | |
| Repurchase of Common Stock | -$42.5M | -- | -- | -- | -$143.9M | |
| Other Financing Activities | $42.3M | -$212.6K | -$441.6K | $9M | $44.2M | |
| Cash From Financing | $28.2M | -$68.1M | -$170.6M | $522M | -$45.8M | |
| Beginning Cash (CF) | $448M | $859.3M | $290.9M | $439.6M | $891.7M | |
| Foreign Exchange Rate Adjustment | -$4.1M | -$2.7M | $2M | -$17.4K | -$2.1M | |
| Additions / Reductions | -$102.7M | -$59.6M | $64M | $567.9M | $74.2M | |
| Ending Cash (CF) | $341.2M | $797M | $356.9M | $1B | $963.8M | |
| Levered Free Cash Flow | -$85.3M | $105.8M | $144.6M | -$561.4M | $57.5M | |
Get STNE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
STNE
Sector
P/E ratio
7.97x
11.69x
PEG ratio
0.08x
0.38x
P/B ratio
1.99x
1.06x
Price / LTM sales
1.84x
2.51x
Growth Metrics
STNE
Sector
Revenue growth
-0.27%
5.06%
Earnings growth
28.83%
2.87%
Revenue (5-year growth)
31.4%
5.19%
Earnings forecast
$0.33
$0.56
Profitability
STNE
Sector
Profitability FY 2024
$1.7B
$139.2M
Return on invested capital
-5.01%
5.28%
Return on assets
-2.31%
0.97%
Return on equity
-8.83%
9.24%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
14
Estimated Next Earnings Date
Aug
7
Balance Sheet
STNE
Sector
Total cash
$1.4B
$465.7M
Short term investments
$1.5B
$233.6M
Total assets
$8.9B
$4B
Long term debt
$2.3B
$293.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Howard Marks Buy Grab Stock?
When a legendary value investor who cut his teeth in…
Why Did Warren Buffett Buy Amazon Stock?
When investors think of tech stocks in Warren Buffett’s portfolio,…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
88
CDTX alert for Jun 24
Cidara Therapeutics [CDTX] is up 3.18% over the past day.
Sell
46
HIMS alert for Jun 24
Hims & Hers Health [HIMS] is up 2.26% over the past day.
Buy
67
WGS alert for Jun 24
GeneDx Holdings [WGS] is up 13.99% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
